Gregg Feigelson
About Gregg Feigelson
Gregg Feigelson is a Senior Director at Bristol-Myers Squibb with over 30 years of experience in the pharmaceutical industry, specializing in organic chemistry and drug discovery.
Company
Gregg Feigelson currently works at Bristol-Myers Squibb as a Senior Director in Summit, NJ. Prior to this role, he held several key positions in major pharmaceutical companies such as Celgene and Pfizer, showcasing his extensive experience in the industry.
Title
Gregg Feigelson holds the position of Senior Director at Bristol-Myers Squibb. He has also served as Senior Director at Celgene and Principal Research Scientist II at Pfizer during his lengthy career in the pharmaceutical industry.
Education and Expertise
Gregg Feigelson obtained his PhD in Organic Chemistry from Yale University, where he studied from 1983 to 1987. He also earned a BS in Chemistry from the University of California, Santa Cruz, completed in 1981. His expertise lies in organic chemistry, with a specialization in drug discovery and development.
Background
With over 30 years in the pharmaceutical industry, Gregg Feigelson has worked at prominent organizations such as American Cyanamid, Pfizer, and Celgene. He has a strong background in research and development, particularly in oncology and medicinal chemistry.
Achievements
Throughout his career, Gregg Feigelson has contributed to several high-impact research publications and has been involved in developing multiple FDA-approved drugs. He has been recognized for his contributions to medicinal chemistry and has a proven track record of leading cross-functional teams to achieve significant project milestones.